<DOC>
	<DOCNO>NCT00168896</DOCNO>
	<brief_summary>Comparison two combination chemotherapy treatment patient SLCL</brief_summary>
	<brief_title>A Study Small Cell Lung Cancer ( SCLC ) Extensive Disease Stage</brief_title>
	<detailed_description>Comparison two combination chemotherapy treatment patient SLCL The combination chemotherapy study Carboplatin plus Irinotecan versus Carboplatin plus Etoposide .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<criteria>cytological histological proven SCLC Stage I II 1st diagnosis prior chemotherapy measurable tumor disease karnofsky performance 70 second malignancy ( except basal cell carcinoma , CA situ Cervix uterus ) NYHA III chronic diarrhea , obstructive bowel syndrome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2001</verification_date>
	<keyword>SCLC</keyword>
</DOC>